Skip to main content
. 2022 Jan 25;15:249–260. doi: 10.2147/IDR.S344875

Table 3.

Resistance Rates of Acinetobacter baumannii and Pseudomonas aeruginosa to the Common Antibiotics

Acinetobacter baumannii Pseudomonas aeruginosa
1998–2002 2003–2007 2008–2012 2013–2017 1998–2002 2003–2007 2008–2012 2013–2017
n R (%) n R (%) n R (%) n R (%) n R (%) n R (%) n R (%) n R (%)
Penicillins
Piperacillin (100ug) 9 22.2 64 50 341 69.5 760 78.8 99 24.2 189 29.1 473 23.7 1065 21.4
β-Lactam combinationagents
Cefoperazone sulbactam (75/75ug) / / 62 12.9 299 24.4 643 63.1 / / / / / / / /
Piperacillin Tazobactam (100/10ug) / / 36 41.7 245 62 876 74.9 / / 89 19.1 334 13.2 1046 15.6
Cephems
Ceftazidime (30ug) 10 30 68 42.6 351 63 879 76.5 100 26 191 18.8 471 21 1079 19
Cefepime (30ug) / / 65 38.5 310 62.9 986 75.4 / / 175 17.7 465 21.3 1081 19.9
Carbapenems
Imipenem (10ug) / / 68 23.5 334 61.1 989 74.4 95 16.8 189 21.2 473 23.7 1079 30.6
Meropenem (10ug) / / 30 20 272 58.1 829 76.1 / / 87 14.9 381 21.8 935 25.6
Aminoglycosides
Amikacin (30ug) 10 20 64 39.1 351 59.8 916 67.7 101 16.8 186 17.7 480 20.2 1063 14.3
Gentamicin (10ug) 10 40 65 49.2 344 67.4 986 75.5 103 23.3 186 29.6 468 26.3 1075 21.2
Fluoroquinolones
Ciprofloxacin (5ug) 10 40 63 31.7 317 57.7 969 74.5 98 17.3 187 17.1 423 18.4 1069 17.5
Levofloxacin (5ug) / / 46 28.3 273 57.9 928 69.6 / / 107 21.5 326 13.8 939 17.3
Folate pathway antagonists
Trimethoprim/sulfamethoxazole (1.25/23.75ug) 8 25 68 50 268 63.4 962 74.3 / / / / / / / /

Note: “/” indicated that the antibiotics had not been tested.